Takeda Pharmaceutical (4502 JT) 2025/26 (JPY): Revenue 4.51tln (prev. 4.6tln Y/Y), Net -152.4bln (prev. +107.9bln Y/Y), Operating profit 6.22bln (prev. 342.6bln Y/Y)

#TAKEDA PHARMACEUTICAL CO LTD#4502.JT#EU SESSION#JPY#ASIAN EQUITIES
Published: Updated: